Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer

Despite increasing options for treatment of castration-resistant prostate cancer, development of drug resistance is inevitable. The glucocorticoid receptor (GR) is a prime suspect for acquired therapy resistance, as prostate cancer (PCa) cells are able to increase GR signaling during anti-androgen t...

Descripción completa

Detalles Bibliográficos
Autores principales: Puhr, Martin, Eigentler, Andrea, Handle, Florian, Hackl, Hubert, Ploner, Christian, Heidegger, Isabel, Schaefer, Georg, Brandt, Maximilian P., Hoefer, Julia, Van der Pluijm, Gabri, Klocker, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084733/
https://www.ncbi.nlm.nih.gov/pubmed/33795839
http://dx.doi.org/10.1038/s41388-021-01754-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084733/
https://www.ncbi.nlm.nih.gov/pubmed/33795839
http://dx.doi.org/10.1038/s41388-021-01754-0

Ejemplares similares